5-HT2A receptor antagonist M100907 reduces serotonin synthesis: an autoradiographic study.
Shu Hasegawa, Maraki Fikre-Merid, Mirko Diksic
Index: Brain Res. Bull. 87(1) , 44-9, (2012)
Full Text: HTML
Abstract
The effects of the administration of the serotonin (5-HT)(2A) antagonist, M100907, on 5-HT synthesis rates, were evaluated using the α-[(14)C]methyl-l-tryptophan (α-MTrp) autoradiographic method. In the treatment study, M100907 (10mg/kg) was injected intraperitoneally 30 min before the α-MTrp injection (30 μCi over 2 min). A single dose of M100907 caused a significant decrease in the synthesis in the anterior olfactory nucleus, accumbens nucleus, frontal cortex, sensory-motor cortex, cingulate cortex, medial caudate-putamen, dorsal thalamus, substantia nigra, inferior collicus, raphe magnus nucleus, superior olive, and raphe pallidus nucleus. These data suggest that the terminal 5-HT(2A) receptors are involved in the regulation of 5-HT synthesis in the entire brain. Further, 5-HT synthesis is likely regulated by the 5-HT(2A) antagonistic property of M100907 in the cortices, anterior olfactory nucleus, caudate putamen, and nucleus accumbens.Copyright © 2011 Elsevier Inc. All rights reserved.
Related Compounds
Related Articles:
2015-04-01
[Neuropharmacology 91 , 23-33, (2015)]
Serotonin 2A receptor antagonists for treatment of schizophrenia.
2011-09-01
[Expert Opin. Investig. Drugs 20(9) , 1211-23, (2011)]
2012-07-01
[Synapse 66(7) , 650-60, (2012)]
2012-01-01
[Psychopharmacology 219(2) , 633-45, (2012)]
2012-12-01
[Synapse 66(12) , 989-1001, (2012)]